Skip to main content

Table 1 Resting NK signature derived from Affymetrix and spotted microarray platform.

From: Genome wide transcriptional analysis of resting and IL2 activated human natural killer cells: gene expression signatures indicative of novel molecular signaling pathways

  

Median fold change (Range)

Gene ontogeny

Gene symbols

Spotted

Affymetrix

Cell cycle regulators

BTG1, JAG1, MATK, TGFBR3, TINF2, TMEPAI, NEK1, CCND2, CCNC, BIN1, HEXIM1, PPP2R5A, CARF

2.59 (2.01–5.06)

3.76 (2.87–7.05)

Cytotoxicity

CRTAM, CTSW, DPP8, FASLG, FNBP1, GNLY, GZMA, GZMH, HCST, LITAF, PRF1, TNFRSF1B, TNFSF14, NEK1, CASP10, STK17B, CTSC, PRSS23

4.48 (2.36–12.76)

4.43 (2.8–19. 42)

Cytokines

CCL5, CX3CR1, IL18R1, IL18RAP, IL21R, PPBP(CXCL7)

7.12 (2.9–17.56)

5.93 (2.86–29.7)

Inflammatory response

C3AR1, PDE7A, LY75, RORA, AOAH, ARF6, C1orf38, CLEC2B, IRF1

3.12 (2.20–6.56)

5.06 (2.83–11.01)

Regulators of immune response

PTPN4(negative regulators), PPP2R2B, SLA2, ID2, KLF11, ZFHX1B

3.18 (2.36–8.6)

9.92 (2.84–11.39)

Secretory pathway and protein maturation

GALNT11, GNPTAB, RAMP1, SEC22L3, SLC38A1, TES, TPST2, WDFY1, GALNT7, DNAJC3, SLC35E1, ZNF12

3.88 (2.90–9.01)

4.34 (3.00–4.96)

Transcription factors and accessory regulators

BHLHB2, EOMES, KBTBD2, MAF, NFAT5, THRAP3, TXK, ZBTB11, ZNF267, ZNF394, ZNF12, HCF2, MLLT10, MLL3, SSRPN, TAF1, MLR1, ZNF614, EIF2C4, EIF1AY, EIF2C2,

3.55 (2.58–7.44)

3.71 (2.88–4.9)

Regulation of GTPase activity

CENTD1, PLEK, PREX1, RAB7L1, RASGRP1, RGS18, RGS3, RIN3, PCTK2, RAB27B

4.16 (2.91–5.67)

4.43 (3.64–6.8)

Proliferative

GFI1, SMAD5, ZBTB16, AKT3, SMC5L1, RNF139

2.90 (2.90–22.16)

3.02 (3.02–5.3)

Cytoskeleton orgnisation

DOCK5, DOCK8, DOK2, MACF1, MYOM2, PHLDB2

3.41 (2.73–6.21)

3.51 (2.94–8.50)

Metabolism and nucleotide biosynthesis

DCY7, ATP6AP2, CHST12, CLIC3, GFOD1, PARP8, TKTL1, YPEL1, ENPP4, DHRS7, BPGM

2.92 (2.25–19.24)

4.98 (2.84–9.55)

Miscellaneous

SBK1, PLAC8, PLCL2, RNF125, SPAG9, MAPK1, C10orf137, C10orf18, C1orf63, C20orf3, FLJ13611, FLJ39739, GALNT10, ZBTB11, BTBD9, C14orf43, BRWD1, FAM62B, BCAP29, C18orf8, LOC285628, KLHL21, KIAA0907, KIAA1450, MOBKL2A, TSPYL1, TRIM39, ULK2, ULK4, WAC, YTHDC2, ZSWIM6

4.16 (2.42–10.13)

4.23 (2.94–8.17)

Cell adhesion and cell surface

ITGAM, ITGB2, ADAM8, FGR, CD300A(Irp60), CD3Z, CD96, FCER1G, CD94 (KLRD1), CD314 (KLRK1), LAIR2, ADD3, CD244, SPN(CD43), KLRF1

3.36 (2.36–8.9)

3.90 (2.4–21.53)

  1. Resting NK signature of genes showing 2 fold higher expression levels on two microarray platforms. A common set of 164 genes were more than 2 fold higher expressed in resting NK cells compared to 1) the lymphoid RNA standard, tonsillar cells and resting CD8+ T cells on spotted microarrays and 2) the lymphoid RNA standard, universal RNA standard (Stratagene Inc, CA) and resting CD8+ T cells on GeneChipU133plus 2® (Affymetrix Inc, CA).